| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |